Harlan and Chad Robins started Seattle-based Adaptive Biotechnologies 12 years ago to find a cure for cancer. Now, they have broadened their mission to take on COVID-19.
Click here for original story, Billion-dollar biotech company’s focus expands to include COVID
Source: Phys.org